trihexyphenidyl has been researched along with Bradykinesia in 2 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sahoo, LK | 1 |
| Holla, VV | 1 |
| Batra, D | 1 |
| Prasad, S | 1 |
| Bhattacharya, A | 1 |
| Kamble, N | 1 |
| Yadav, R | 1 |
| Pal, PK | 1 |
| Ohno, Y | 1 |
| Shimizu, S | 1 |
| Imaki, J | 1 |
| Ishihara, S | 1 |
| Sofue, N | 1 |
| Sasa, M | 1 |
| Kawai, Y | 1 |
2 other studies available for trihexyphenidyl and Bradykinesia
| Article | Year |
|---|---|
Comparison of effectiveness of trihexyphenidyl and levodopa on motor symptoms in Parkinson's disease.
Topics: Antiparkinson Agents; Humans; Hypokinesia; Infant, Newborn; Levodopa; Parkinson Disease; Treatment O | 2020 |
Evaluation of the antibradykinetic actions of 5-HT1A agonists using the mouse pole test.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Behavior, Animal; Disease Mod | 2008 |